|
|||||
|
|
Assessing the impact of patient self‐selection on the costs to treat latent tuberculosis infection (LTBI) with isoniazid and transitional rifampin |
|
| Authors: | Kyle R. Fluegge PhD MPH |
| Affiliation: | 1. Department of Agricultural, Environmental, and Development Economics, Division of Epidemiology, College of Public Health, The Ohio State University, , Columbus, OH, USA;2. Institute of Health and Environmental Research (IHER), , Columbus, OH, USA |
| Abstract: | |
| Keywords: | isoniazid latent tuberculosis infection rifampin selection |